Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Capital Expenditures: 2016-2023

Historic Capital Expenditures for SRx Health Solutions (SRXH) over the last 7 years, with FY2023 value amounting to $18000.0.

  • SRx Health Solutions' Capital Expenditures rose 13333.33% to $7000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $7.0 million, marking a year-over-year increase of 6359090.91%. This contributed to the annual value of $18000.0 for FY2023, which is 9090.91% down from last year.
  • SRx Health Solutions' Capital Expenditures amounted to $18000.0 in FY2023, which was down 9090.91% from $198000.0 recorded in FY2022.
  • In the past 5 years, SRx Health Solutions' Capital Expenditures registered a high of $353000.0 during FY2021, and its lowest value of $18000.0 during FY2023.
  • Its 5-year average for Capital Expenditures is $166000.0, with a median of $151000.0 in 2020.
  • As far as peak fluctuations go, SRx Health Solutions' Capital Expenditures soared by 25483.87% in 2019, and later crashed by 9090.91% in 2023.
  • Over the past 5 years, SRx Health Solutions' Capital Expenditures (Annual) stood at $110000.0 in 2019, then surged by 37.27% to $151000.0 in 2020, then soared by 133.77% to $353000.0 in 2021, then plummeted by 43.91% to $198000.0 in 2022, then tumbled by 90.91% to $18000.0 in 2023.
  • Its Capital Expenditures stands at $18000.0 for FY2023, versus $198000.0 for FY2022 and $353000.0 for FY2021.